Lilac Insights is a specialized genetic diagnostics company pioneering reproductive genetics and cancer genetics services in India. Founded in 2011, the company has established itself as a leader in genetic health assessment through its comprehensive diagnostic services including prenatal screening, newborn genetic testing, cancer genetics program, and clinical genetic consultation. Operating in 100+ cities through a main facility in Navi Mumbai and satellite centers across India, Lilac Insights has tested 650,000+ patient samples and follows international protocols from FMF (UK) and NHS (UK), ensuring high-quality, evidence-based genetic diagnostics for precision medicine.
Genetic disorders and cancer risk factors require specialized diagnostic expertise and interpretation that general diagnostic labs lack. India's healthcare system needs accessible, accurate genetic testing infrastructure to enable early diagnosis, informed family planning decisions, and precision treatment strategies for cancer patients. Lilac Insights addresses this by providing specialized, high-accuracy genetic diagnostics combined with expert genetic counseling, enabling clinicians and families to make confident, informed health decisions.
Lilac Insights exemplifies Rockstud Capital's investment in specialized healthcare solutions addressing India's diagnostic gaps. The company's combination of clinical expertise, international quality standards, and proprietary diagnostic capabilities in high-growth genetic medicine segments aligns with the fund's thesis on building essential healthcare infrastructure addressing underserved medical needs.
Co-Founder & Director
Domain expert in life sciences; leads Lilac Insights' expansion into new genetic diagnostic areas.
Co-Founder & Director
Brings expertise in genetic sciences and laboratory operations; established Lilac's high-quality diagnostic protocols aligned with international standards.
Co-Founder
Contributes healthcare sector expertise and strategic partnerships for expansion across India.